The Met oncogene and basal-like breast cancer: another culprit to watch out for?
Recent findings suggest the involvement of the MET oncogene, encoding the tyrosine kinase receptor for hepatocyte growth factor, in the onset and progression of basal-like breast carcinoma. The expression profiles of basal-like tumors - but not those of other breast cancer subtypes - are enriched for gene sets that are coordinately over-represented in transcriptional signatures regulated by Met. Consistently, tissue microarray analyses have revealed that Met immunoreactivity is much higher in basal-like cases of human breast cancer than in other tumor types. Finally, mouse models expressing mutationally activated forms of Met develop a high incidence of mammary tumors, some of which exhibit basal characteristics. The present review summarizes current knowledge on the role and activity of Met in basal-like breast cancer, with a special emphasis on the correlation between this tumor subtype and the cellular hierarchy of the normal mammary gland.
Gastaldi
Stefania
S
Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo, Torino, Italy.
Comoglio
Paolo M
PM
Trusolino
Livio
L
D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008954:Models, Biological; D018295:Neoplasms, Basal Cell / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction
D019859:Proto-Oncogene Proteins c-met
Cancer Res. 2003 Mar 1;63(5):1101-5
12615728
Nature. 1995 Feb 23;373(6516):699-702
7854452
Science. 1991 Feb 15;251(4995):802-4
1846706
Breast Cancer Res. 2009;11(2):402
19439036
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4324-9
15738393
N Engl J Med. 2004 May 20;350(21):2129-39
15118073
Nat Genet. 1997 May;16(1):68-73
9140397
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4477-82
15070743
Cancer Res. 1999 Jan 15;59(2):307-10
9927037
Int J Cancer. 2005 Feb 10;113(4):678-82
15455388
Nat Genet. 2001 Jul;28(3):266-71
11431698
Oncogene. 2007 May 28;26(25):3637-43
17530017
EMBO J. 1991 Oct;10(10):2867-78
1655405
Annu Rev Med. 2009;60:207-19
19630571
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):365-73
18268121
Clin Cancer Res. 2007 May 1;13(9):2728-37
17473206
Nature. 1995 Aug 31;376(6543):768-71
7651534
J Cell Biol. 2007 Apr 9;177(1):151-62
17403932
Clin Cancer Res. 2007 Apr 15;13(8):2329-34
17438091
Nature. 1989 May 11;339(6220):155-6
2541345
Cancer Res. 2006 Aug 15;66(16):8109-15
16912188
Breast Cancer Res. 2008;10(5):R86
18925950
Clin Cancer Res. 2009 Apr 1;15(7):2207-14
19318488
J Cell Biol. 1998 Oct 19;143(2):533-45
9786961
Oncogene. 2006 Apr 6;25(15):2273-84
16288205
Nature. 2006 Feb 23;439(7079):993-7
16395311
Clin Cancer Res. 2005 Jul 15;11(14):5175-80
16033833
J Natl Cancer Inst. 2009 May 20;101(10):736-50
19436038
Cancer Res. 2006 Apr 1;66(7):3452-5
16585167
Cell Cycle. 2010 Mar 15;9(6):1043-50
20237428
Dev Genet. 1996;18(3):254-66
8631159
J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45
9701363
Breast. 2007 Aug;16(4):327-43
17499991
Nat Med. 2009 Aug;15(8):907-13
19648928
Histopathology. 2007 Jul;51(1):54-62
17593080
Nature. 1995 Feb 23;373(6516):702-5
7854453
J Pathol. 2009 Jan;217(2):229-41
19009588
J Cell Biol. 1993 Oct;123(1):223-35
8408200
Bioessays. 2000 Aug;22(8):728-37
10918303
Cancer. 1997 Feb 15;79(4):749-60
9024713
Tumour Biol. 2007;28(1):36-44
17143015
Mol Cell Proteomics. 2008 Aug;7(8):1420-33
18426791
Development. 1998 May;125(10):1921-30
9550724
Cancer. 1999 Dec 1;86(11):2259-65
10590366
Clin Cancer Res. 1995 Feb;1(2):147-54
9815967
Oncogene. 2003 Nov 20;22(52):8498-508
14627990
Oncogene. 2009 Mar 19;28(11):1421-31
19151767
Oncogene. 2010 Apr 8;29(14):2013-23
20101236
J Clin Oncol. 2008 May 20;26(15):2568-81
18487574
Cell. 2006 Dec 1;127(5):1041-55
17129787
Nat Rev Cancer. 2006 Aug;6(8):637-45
16862193
Clin Cancer Res. 2008 Dec 15;14(24):8010-8
19088017
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20932-7
18093943
Cancer Res. 2008 May 1;68(9):3314-22
18451158
Trends Cell Biol. 1998 Oct;8(10):404-10
9789329
Science. 2004 Jun 4;304(5676):1497-500
15118125
Am J Pathol. 1996 Nov;149(5):1707-17
8909259
Cancer Res. 2010 Apr 1;70(7):2840-51
20332234
Trends Mol Med. 2006 Nov;12(11):537-44
17011236
Oncologist. 2003;8(4):335-41
12897330
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
11553815
Eur J Cancer. 2010 May;46(7):1260-70
20303741
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12903-8
19617568
Gene. 1988 Dec 20;73(2):499-507
2977358
Clin Cancer Res. 2008 Apr 1;14(7):1938-46
18381931
Hum Pathol. 2007 Jun;38(6):830-41
17316758
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17079-84
18971340
Cancer Cell. 2010 Jan 19;17(1):77-88
20129249
Nature. 2001 May 17;411(6835):366-74
11357144
Am J Pathol. 1995 Aug;147(2):386-96
7639332
Oncogene. 1995 Feb 16;10(4):739-49
7862451
Science. 2007 May 18;316(5827):1039-43
17463250
Nature. 2006 Jan 5;439(7072):84-8
16397499
Nat Rev Drug Discov. 2008 Jun;7(6):504-16
18511928
J Cell Biol. 2007 Jan 1;176(1):19-26
17190790
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12909-14
19567831
Science. 2003 Oct 24;302(5645):643-6
14576434
Oncology. 2002;63(3):286-96
12381909
Nat Cell Biol. 2007 Feb;9(2):201-9
17187062
Pathol Int. 2001 Mar;51(3):172-8
11328532
Int J Oncol. 2008 Dec;33(6):1165-76
19020749
J Endocrinol Invest. 1995 Feb;18(2):134-9
7629381
Oncogene. 2001 Nov 8;20(51):7514-23
11709723
Am J Pathol. 1996 Jan;148(1):225-32
8546209
Breast Cancer Res Treat. 1996;39(1):21-31
8738603